Trial Profile
A Phase One, Open Label, Multi-Dose Study to Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Collagen (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Sponsors ImmuneWorks
- 18 Apr 2014 New trial record